Vagus nerve stimulation is a social-media sensation, promising instant stress relief. Here’s what the science really says ...

Primary central nervous system lymphoma (PCNSL) is a rare and highly aggressive lymphoma or tumor of the brain. While ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

It’s one of the tenets of physical fitness, so why is flexibility overlooked by researchers and the average person putting on ...

Total net revenue of $13.9 million Net income of $2.0 million, or $0.21 net income per share basic Adjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments $32.6 million cash ...

Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, announced today it has received a research grant ...

Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and celebrities, pitched ...

The University of Northern Iowa was one of the first schools in the nation to use syndavers. It's now the first higher-ed ...

CuraSen Therapeutics, Inc., a biopharmaceutical company developing drug candidates with broad applicability in neurodegenerative and neuropsychiatric diseases, today announced encouraging results from ...

Native American Heritage Month, Refugia of the Blue Mountains, Scrabble Club, A Shift in Thinking, Honk! Jr. — The Musical ...

It's an unpleasant feeling for us, but is failure necessary for success? A world champion athlete and Duke professor explain why they say yes.

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...